ARS Pharmaceuticals (NASDAQ:SPRY) reported its Q4 earnings results on Monday, March 9, 2026 at 07:00 AM.
Here’s what investors need to know about the announcement.
Earnings
ARS Pharmaceuticals beat estimated earnings by 8.7%, reporting an EPS of $-0.42 versus an estimate of $-0.46.
Revenue was down $58.51 million from the same period last year.
Analysis of Past Earnings
The company missed on …